SLC2A5 and cancer: Cancer cells express solute carrier family member 5 (SLC2A5), the fructose transporter, and upregulation of SLC2A5 is indicative of a poor prognosis for cancer patients that experienced an increase in cancer cell proliferation, colony growth, and metastasis [10].